Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 242
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT05540327 The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or S… |
M5049 low dose | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | United States, Argentina, Australia, Brazil, Bulgaria… | 2022-09-16 → 2028-08-12 | Ouvrir |
| NCT07087912 BTNDV-ARD — Safety and Immunogenicity of the Live Attenuated Tetravalen… |
Dengue 1,2,3,4 (attenuated) vacci… | Lupus | Phase 4 | RECRUITING | En attente / non publié | University of Sao Paulo General H… | Brazil · Hospital das Clinicas da Faculdade de Medici… | 2026-03-16 → 2028-12-30 | Ouvrir |
| NCT07716462 MIGHT-SLE — Home-Based High-Intensity Interval Training in Systemic Lup… |
MIGHT-SLE — Home-Based High-Inten… | Lupus | Non applicable | NOT_YET_RECRUITING | En attente / non publié | University of Alabama at Birmingh… | United States · University of Alabama at Birmingham, … | 2026-10-01 → 2027-12 | Ouvrir |
| NCT06594068 PRIMULA Lac — Prospective Registry Investigating Maternal, Infant, and … |
Anifrolumab | Lupus | Phase 4 | RECRUITING | En attente / non publié | University of Cambridge | United States · Research Site, Las Vegas, United Stat… | 2026-01-16 → 2027-08-31 | Ouvrir |
| NCT05966480 LUMUS — Phase 2 Placebo-Controlled Study to Assess the Safety and Effic… |
Envudeucitinib | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Alumis Inc | United States, Argentina, Bulgaria, Chile, Colombia, … | 2023-06-26 → 2027-09-01 | Ouvrir |
| NCT04221477 REGENCY — A Study to Evaluate the Efficacy and Safety of Obinutuzumab i… |
Obinutuzumab | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Hoffmann-La Roche | United States, Argentina, Brazil, Colombia, France, G… | 2020-08-10 → 2031-03-02 | Ouvrir |
| NCT07175285 BENCHMARK-SLE — A Study in Participants With Active Systemic Lupus Eryt… |
BENCHMARK-SLE — A Study in Partic… | Lupus | À vérifier | RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Argentina, Brazil, Canada, France, Ger… | 2025-10-08 → 2032-10-05 | Ouvrir |
| NCT07330245 DAHLIA — Achievement of LLDAS5 in Patients With Systemic Lupus Erythema… |
Anifrolumab | Lupus | À vérifier | RECRUITING | En attente / non publié | University of Cambridge | Italy · AOU Ospedali Riuniti di Ancona - Presidio Tor… | 2025-12-31 → 2028-09-30 | Ouvrir |
| NCT07720310 Anti-CD19 CAR-T Cell Therapy for Patients With Refractory Systemic Lupu… |
CAR T cells chimeric antigen rece… | Lupus | À vérifier | ENROLLING_BY_INVITATION | En attente / non publié | N.N. Alexandrov National Cancer C… | Belarus · NN Alexandrov National Cancer Centre of Bel… | 2026-03-09 → 2030-06 | Ouvrir |
| NCT07719322 Non Invasive Assessment of Subclinical Atherosclerosis and Cardiovascul… |
Non Invasive Assessment of Subcli… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Egypt · Assuit university hospitals, Asyut, Egypt | 2026-07 → 2029-07 | Ouvrir |
| NCT07719140 Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonizati… |
High-dose prednisone | Lupus | Phase 4 | RECRUITING | En attente / non publié | Peking Union Medical College Hosp… | China · Beijing Children's Hospital, Capital Medical … | 2026-07 → 2029-03 | Ouvrir |
| NCT06799520 A Phase 1 Trial to Evaluate the Safety, Tolerability, Pharmacodynamics,… |
VIS171 | Lupus | Phase 1 | ACTIVE_NOT_RECRUITING | En attente / non publié | Otsuka Pharmaceutical Development… | Bulgaria, Moldova, Romania, Spain · Visterra Investig… | 2025-03-17 → 2027-02-19 | Ouvrir |
| NCT07430306 SUNFLOWER — A Study to Evaluate the Treatment Outcomes of Subcutaneous … |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | University of Cambridge | United States, Canada, France, Germany, Italy, Mexico… | 2026-04-13 → 2029-01-26 | Ouvrir |
| NCT07721324 SLE — Effect of Melatonin Administration on Systemic Lupus Erythematosu… |
Melatonin | Lupus | Phase 2/3 | NOT_YET_RECRUITING | En attente / non publié | Nishtar Medical University | Egypt · Department of Rheumatology Ain Shams Universi… | 2026-07-21 → 2026-11-21 | Ouvrir |
| NCT07721857 Neutrophil Extracellular Traps and Lupus Nephritis |
Neutrophil Extracellular Traps an… | Lupus | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Assiut University | Non communiqué | 2026-09-01 → 2028-10-31 | Ouvrir |
| NCT07721363 OBLUMEN — Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous… |
Obinutuzumab | Lupus | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Hoffmann-La Roche | France · Sorbonne University - Nephrology Départment … | 2026-09-02 → 2029-09-02 | Ouvrir |
| NCT06217107 Wellness & Workforce Solution for Lupus/Lupus Nephritis |
Wellness & Workforce Solution for… | Lupus | Non applicable | RECRUITING | En attente / non publié | Morehouse School of Medicine | United States · Morehouse School of Medicine, Atlanta… | 2024-09-14 → 2026-12-31 | Ouvrir |
| NCT07089121 Descartes-08 for Children, Adolescents, and Young Adults With Autoimmun… |
Descartes-08 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Cartesian Therapeutics | United States · Cincinnati Children's Hospital Medica… | 2026-01-14 → 2028-12 | Ouvrir |
| NCT02472795 Clinical Study to Investigate the Biological Activity, Safety, Tolerabi… |
Cenerimod | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Viatris Innovation GmbH | United States, Belarus, Bulgaria, Georgia, Russia, Uk… | 2015-06-01 → 2017-02-28 | Ouvrir |
| NCT06947460 CD19-BCMA CART Cell Therapy for Refractory SLE-LN, SSc, and pSS-PAH |
CD19-BCMA CAR-T cells infusion | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Beijing GoBroad Hospital | China · 北京高博医院, Beijing, China | 2025-04-18 → 2026-07-31 | Ouvrir |
| NCT06032923 Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Bo… |
Double-blind Placebo Controlled S… | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | National Heart, Lung, and Blood I… | United States · National Institutes of Health Clinica… | 2024-03-13 → 2028-08-01 | Ouvrir |
| NCT07564596 A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) |
Budoprutug | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Climb Bio, Inc. | China · Baoji Central Hospital, Baoji, China | Mianya… | 2026-06-30 → 2027-09 | Ouvrir |
| NCT05835310 BLOSSOM — An Efficacy and Safety Study of Intravenous Anifrolumab to Tr… |
Anifrolumab | Lupus | Phase 3 | RECRUITING | En attente / non publié | University of Cambridge | United States, Argentina, Brazil, Canada, China, Colo… | 2024-03-14 → 2030-01-09 | Ouvrir |
| NCT06897930 A Study to Investigate the Safety, Tolerability, and Efficacy of AZD012… |
AZD0120 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Tongji Hospital | United States, Australia, Canada, United Kingdom · Re… | 2025-04-21 → 2029-05-01 | Ouvrir |
| NCT05531565 AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Inject… |
Litifilimab | Lupus | Phase 2/3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Biogen | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2022-09-13 → 2027-12-14 | Ouvrir |